Status:
COMPLETED
Clinical Verification of Peptide Biomarkers for Type 2 Diabetes Mellitus
Lead Sponsor:
Beijing Institute of Technology
Conditions:
Diabetes Mellitus, Type 2
Eligibility:
All Genders
35-72 years
Brief Summary
Although diabetes has been controlled since insulin became available, it is still considered incurable and poses serious threats to human health. Reports have suggested that the hyperglycemic conditio...
Detailed Description
The procedure of clinical study was: 1. to get plasma samples from hospital; 2. digestion of plasma protein-mixture by trypsin; 3. run mass spectrometry and monitor the amount of target HSA-peptides.
Eligibility Criteria
Inclusion
- Type 2 Diabetes Mellitus cases;
- Impaired Glucose Tolerance cases;
- Normal Glucose Tolerance cases
Exclusion
- Type 1 Diabetes Mellitus cases;
- Gestational Diabetes Mellitus cases;
- Hepatitis patients
Key Trial Info
Start Date :
January 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2011
Estimated Enrollment :
389 Patients enrolled
Trial Details
Trial ID
NCT01902316
Start Date
January 1 2009
End Date
December 1 2011
Last Update
July 18 2013
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.